Items Tagged ‘Trial Assigning Individualized Options for Treatment (Rx)’

October 8th, 2015

Low Oncotype® Recurrence Score® Identifies Group of Women with Early Stage Breast Cancer That can Avoid Chemotherapy


The results of a study presented at the European Cancer Congress demonstrate that early-stage breast cancer patients with a low Oncotype DX® Recurrence Score® result of 10 or less who received hormonal therapy alone without chemotherapy had less than a one percent chance of distant recurrence at five years. The results are the first to be […]

View full entry

Tags: Breast Cancer, clinical trial, early-stage breast cancer, News, oncotype dx, Stage I Node Negative Breast Cancer, Tailorx, Trial Assigning Individualized Options for Treatment (Rx)